A novel cyclodepsipeptide of fungal origin, PF 1 022A, recently was reported to have anthelmintic activity. To supplement published reports and determine potential utility of PF1022Aas a ruminant anthelmintic, the compoundwas examinedin in vitro and in vivo models. Assays used measured motility of Haemonchus contortus (intrinsic drug potency), ATP levels (parasite death), and activity against H. contortus, Ostertagia ostertagi, and Trichostrongylus colubriformis in the jird (spectrum, potency, and efficacy by various routes). The potency of PF1022Ain reducing motility is greater than commercial anthelmintics. Examination of ATPlevels in PF1022A-paralyzed H. contortus indicates that wormsare not killed, suggesting the compoundacts as a neurotoxin in nematodes. In the jird, PF1022Ahas activity orally against each of the parasites studied and at doses comparable to all commercial anthelmintics, except the macrocyclic lactones which are more potent.
Unfortunately, for some nematode species, parenteral delivery is ineffective at realistic doses. produced no signs of acute toxicity in mice. To supplement these results and determine the potential utility of PF1022Aas a ruminant anthelmintic, we examined the compound in a variety of in vitro and in vivo models.
Results of these studies are reported herein.
Materials and Methods
Compound PF1022A ( Fig. 1) was produced synthetically at The
Upjohn Company using the methods described by AUG. 1995 Dutton and Nelson4). The standards used in these studies were levamisole (Sigma Chemical Co.), albendazole (Smith Kline Beecham), and ivermectin (Merck & Co.).
Motility Assay
In vitro motility assays using adult female H. contortus were conducted to determine the intrinsic potency of PF1022A relative to broad-spectrum anthelmintics.
Details regarding collection of parasites, other materials used, and the operation of the automated micromotility recording system were described previously by Geary et and heat-killed worms. Figure 3 shows that, although paralyzed, PF1022A-treated H. contortus contain ATP at levels comparable to wormstreated with vehicle (DMSO) only, while heat-killed parasites exhibit little ATP. These data suggest PF1022Aacts as a neurotoxin in nematodes.
In the jird, PF1022A has excellent activity against each of the 3 nematode species examined, whenadministered PO. Table 1 shows the oral 95%effective dose for each parasite in the jird for PF1022A compared to representative compoundsfrom each of the 3 classes of broad- Each data point represents the mean (+SE) motility value, normalized to percent of DMSOcontrols, from at least 5 separate experiments. appears to lack useful parenteral activity against some species.
